Smith 2001.
Methods | Randomized, double‐blind, placebo‐controlled. Weight loss trial. | |
Participants | 485 patients from primary care. 52 week follow‐up. Mean age 42 y. Mean BMI 32.7 kg/m2. Mean weight 87 kg. UK. | |
Interventions | Sibutramine 10 mg daily (n=161). Attrition rate 42%. Sibutramine 15 mg daily (n=161). Attrition rate 49%. Placebo (n=163). Attrition rate 51%. | |
Outcomes | weight loss, 5% and 10% responders, BMI, waist circ, waist‐hip ratio, total cholesterol, triglycerides, glucose, uric acid, blood pressure, heart rate | |
Notes | Co‐intervention: diet counseling | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Low risk | A ‐ Adequate |